As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...
CAR-T therapy's cost per QALY is approximately $100,000, with consistent results across PSM, STM, and DES models. DES uniquely incorporates wait time, significantly affecting CAR-T's ...
Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...
To address the gap between opportunity costs and cost-effectiveness thresholds, we must identify the marginal cost of a unit of health for health care systems. Amid efforts to reduce spending on ...
Patterns of Complementary Medicine Utilization in Patients With Breast Cancer and Colorectal Cancer: A Cross-Sectional Study at a Tertiary Referral Hospital in Yogyakarta, Indonesia A partitioned ...
Greater flexibility in cost-effectiveness thresholds used by health technology assessment bodies may appear manageable in isolation. But these shifts can reshape drug pricing far beyond national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results